Abstract
Introduction
Xanthogranulomatous cholangitis is an extremely rare diagnosis and is believed to be an extension of xanthogranulomatous cholecystitis, a benign inflammatory process characterized by lipid-laden foamy macrophages (called “xanthoma cells”) occurring in a background of chronic inflammation consisting of lymphocytes, plasma cells, and eosinophils. Here, we report a case of xanthogranulomatous cholangitis mimicking cholangiocarcinoma.
Case presentation
A 72 year old male with history of recurrent cholangitis had preoperative workup highly suggestive of intrahepatic cholangiocarcinoma. He underwent right hepatectomy and portal lymphadenectomy, with pathology showing xanthogranulomatous cholangitis, with no evidence of malignancy. Interestingly, the patient did not have xanthogranulomatous cholecystitis.
Discussion
We reviewed the current literature on xanthogranulomatous cholangitis, and identified only 14 previously reported cases. In our case series, there were six female and eight male patients. Among the 14 patients, 11 presented to the hospital with jaundice. Twelve patients had preoperative workup concerning for malignancy. The diagnosis of xanthogranulomatous cholangitis was confirmed through pathology in 13 patients, and through endoscopic ultrasound biopsy in one patient. In our review, seven patients had associated xanthogranulomatous cholecystitis, three patients had an isolated case of xanthogranulomatous cholangitis, and four patients had unknown status. Our patient is the fourth case of isolated xanthogranulomatous cholangitis without xanthogranulomatous cholecystitis.
Conclusion
Xanthogranulomatous cholangitis is a very rare phenomenon that can lead to benign strictures of the bile ducts, especially in the setting of recurrent cholangitis. It can mimic malignancies, such as cholangiocarcinoma, and should be considered in the differential diagnosis.
Keywords: Xanthogranulomatous cholangitis, Cholangiocarcinoma, Xanthogranulomatous cholecystitis, Case series: Biliary abnormalities
Highlights
-
•
Xanthogranulomatous cholangitis is an extremely rare inflammatory process.
-
•
It involves lipid-laden macrophages of the bile duct.
-
•
Patients with xanthogranulomatous cholangitis frequently present with jaundice.
-
•
It can mimic malignancies, including bile duct, liver, gallbladder, and pancreatic cancers.
-
•
It should be included in the differential diagnosis of biliary abnormalities
1. Introduction
Xanthogranulomatous inflammation is a rare, benign inflammatory process that can occur anywhere in the body, including the kidney and gallbladder. It is characterized histologically by lipid-laden macrophages, lymphocytes, plasma cells, eosinophils, and fibrosis. Xanthogranulomatous cholecystitis is believed to be caused by extravasation of bile into the gallbladder wall, leading to an inflammatory reaction that involved phagocytosis of bile pigment by macrophages, resulting in the formation of xanthoma cells. Xanthogranulomatous cholangitis is theorized to be an extension of the xanthogranulomatous cholecystitis into the bile ducts [1]. The diagnosis of xanthogranulomatous cholangitis is difficult to establish. Here, we present a case of isolated xanthogranulomatous cholangitis, without xanthogranulomatous cholecystitis, mimicking cholangiocarcinoma. This case is reported in line with the SCARE criteria [2] and PROCESS 2020 guidelines [3].
2. Presentation of a case
A 72-year-old male who was previously admitted to a tertiary academic hospital for gallstone pancreatitis, recurrent cholangitis managed with endoscopic retrograde cholangiopancreatography (ERCP), and Klebsiella bacteremia underwent interval laparoscopic cholecystectomy with liver biopsy. Upon insufflation of his abdomen, it was noted that his gallbladder was tense, distended, and extrahepatic. Cholecystectomy was performed without any complications. Pathology of his gallbladder revealed chronic cholecystitis and pathology of his liver biopsy was negative for fibrosis, steatosis and inflammation. His postoperative course was complicated by continued night sweats, unintentional weight loss, and jaundice. He underwent ERCP with exchange of common bile duct stents multiple times with no alleviation of symptoms.
On workup, his liver function tests remained mildly elevated (Total bilirubin 1.3 MG/DL, Aspartate Aminotransferase (AST) 78 IU/L, Alanine Aminotransferase (ALT) 64 IU/L, Alkaline Phosphatase 673 IU/L). His carcinoembryonic antigen (CEA) was normal at 1.1 NG/ML but carbohydrate antigen 19-9 (CA19-9) was significantly elevated at 160 U/ML. A computed tomography (CT) scan of abdomen/pelvis showed new intrahepatic ductal dilation and portal vein thrombus without evidence of a liver mass (Fig 1A). Magnetic resonance cholangiopancreatography (MRCP) demonstrated irregular, biliary ductal dilatation. ERCP with SpyGlass revealed right hepatic system underfilling, narrowing of the right intrahepatic duct takeoff, and abnormal biliary tract mucosa characterized by nodularity, scarring, purulence, and decreased vascularity (Fig 1B). Cytology of the right main hepatic duct showed atypical cells. As a result, there was high clinical suspicion of early intrahepatic cholangiocarcinoma. After extensive discussion with patient, he was consented for liver resection.
Fig. 1.
A. CT abdomen/pelvis showing significant intrahepatic biliary ductal dilatation B. ERCP with SpyGlass showing nodularity at the right main hepatic duct.
The patient subsequently underwent right hepatectomy and portal lymphadenectomy (Fig 2A). His pathology showed xanthogranulomatous cholangitis of large hepatic bile ducts, bile granuloma, hepatic parenchyma with features of large bile duct obstruction, chronic cholestasis, and biliary pattern of fibrosis with bridging septa (Fig 2B). There was no evidence of malignancy. Dedicated stains for bacteria and fungi were negative. He was discharged home on postoperative day 4.
Fig. 2.
A. Gross specimen of the right lobe of liver B. High power view showing characteristic xanthoma cells, the lipid-laden foamy macrophages which display an eosinophilic to clear, vacuolated or granular cytoplasm, some seen here with ingested bile.
He subsequently developed recurrent perihepatic abscesses managed with image guided drain placements and right pleural effusions managed with pigtail chest tube placements. Cultures from his perihepatic abscesses were positive for Klebsiella for which he had completed a course of intravenous ertapenem. At his last clinic follow up, patient reported doing well.
3. Discussion
Xanthogranulomatous cholangitis is an extremely rare disorder. A literature review on Pubmed revealed only 14 previously identified cases (Table 1). In our review, six patients were female and eight were male. The most common presenting symptom for patients was jaundice (11 patients) with concern for cholangitis in five patients. Three patients presented with abdominal pain. One patient was asymptomatic and was found to have an incidental finding of hepatic mass on CT scan. Among the patients, nine had elevated bilirubin (ranges 3.2 to 23 MG/DL), and two had normal bilirubin. For 12 patients, there was preoperative diagnosis concerning for malignancy which included primary hepatic neoplasm, pancreatic cancer, gallbladder cancer, and cholangiocarcinoma. Among these 12 patients, 10 of them had imaging suggestive of malignancy while two had cytology suggestive of malignancy. Thirteen patients had surgical resections including pancreaticoduodenectomy (3 patients), hepatic resections (4 patients), bile duct resections with hepaticojejunostomy (4 patients), and resection of a hilar mass with hepaticoduodenostomy (1 patient). In one patient, the diagnosis of xanthogranulomatous cholangitis was confirmed by endoscopic ultrasound.
Table 1.
Previously reported cases of xanthogranulomatous cholangitis.
| Reference | Age | Sex | Presenting symptoms | Bilirubin (MG/DL) | Preoperative diagnosis | Operation | Diagnosis | Xanthogranulomatous cholecystitis |
|---|---|---|---|---|---|---|---|---|
| Goldar-Najafi et al. [9] | 56 yo | F | Abd pain | wnl | Imaging suggestive of hepatic malignancy | Liver resection | Pathology | Unknown |
| 45 yo | M | Jaundice | 4.4 | Imaging suggestive of pancreatic malignancy | Pancreaticoduodenectomy | Pathology | Unknown | |
| Pantanowitz et al. [10] | 75 yo | F | Recurrent cholangitis | Imaging suggestive of cholangiocarcinoma | L hepatic segmentectomy, CCY | Pathology | Unknown | |
| Kawate et al. [11] | 34 yo | F | Jaundice | 7.5 | Bile cytology suggestive of class V adenocarcinoma | Extended R hepatectomy, extrahepatic bile duct resection | Pathology | No |
| Krishna et al. [12] | 55 yo | M | Jaundice, cholangitis | 11.7 | ERCP cytology suggestive of cholangiocarcinoma | CCY, CBD excision, RNY hepaticojejunostomy | Pathology | Yes |
| 43 yo | F | Jaundice, abd pain, cholangitis | 3.2 | Imaging suggestive of gallbladder carcinoma/hilar cholangiocarcinoma | CCY, RNY hepaticojejunostomy | Pathology | Yes | |
| 48 yo | F | Jaundice, cholangitis | 7.9 | Imaging suggestive of periampullary malignancy | Pancreaticoduodenectomy | Pathology | Yes | |
| 56 yo | M | Jaundice, cholangitis | 3.2 | Imaging suggestive of hilar cholangiocarcinoma | R hepatectomy, RNY L hepaticojejunostomy | Pathology | Yes | |
| Alsheik et al. [13] | 37 yo | M | Jaundice, weight loss, diarrhea | 4.4 | CCY | Pathology | Yes | |
| Jun et al. [14] | 67 yo | M | Jaundice, abd pain | 5.3 | Imaging suggestive of pancreatic cancer | Pancreaticoduodenectomy | Pathology | No |
| Garg et al. [15] | 32 yo | F | Jaundice, fever | 23 | Imaging suggestive of gallbladder cancer | Radical CCY with CBD excision, RNY hepaticojejunostomy | Pathology | Yes |
| Bae et al. [1] | 80 yo | M | Asymp | wnl | Imaging suggestive of cholangiocarcinoma | Left lobectomy | Pathology | Unknown |
| Zbaida et al. [16] | 9 mo | M | Jaundice | Imaging suggestive of cholangiocarcinoma | Resection of hilar mass, CCY, hepaticoduodenostomy | Pathology | No | |
| Ikezawa et al. [17] | 70s yo | M | Jaundice | None | EUS/FNA | Yes | ||
| Our patient | 72 yo | M | Weight loss, abd pain, jaundice | 1.3 | Imaging and EUS suggestive of cholangiocarcinoma | Right hepatectomy, portal lymphadenectomy | Pathology | No |
Abd = Abdominal. Asymp = Asymptomatic. CBD = Common bile duct. CCY = Cholecystectomy. F = female. L = left. M = Male. R = right. RNY = Roux-en-y. Wnl = within normal limits.
Interestingly, seven patients had concurrent diagnosis of xanthogranulomatous cholecystitis. There had only been three previously recorded cases of isolated xanthogranulomatous cholangitis without cholecystitis, with our patient being the fourth case. The etiology of isolated xanthogranulomatous cholangitis is unknown. In patients with concurrent xanthogranulomatous cholecystitis, it has been hypothesized to be an extension of the inflammatory reaction from the gallbladder into the bile ducts [1]. In isolated cases of xanthogranulomatous cholangitis, the bile duct wall is infiltrated with foamy macrophages leading to inflammation, fibrosis, and scarring [4]. Perhaps, in this patient, it is secondary to his recurrent episodes of cholangitis, leading to chronic bile duct inflammation, scarring, and a xanthogranulomatous reaction.
The diagnosis of xanthogranulomatous cholangitis is also elusive, with most of the diagnoses confirmed only after pathologic examination of specimens following surgical resection. However, several CT and MRI findings have been correlated with xanthogranulomatous cholecystitis [5]. Zhao at el determined that CT features of diffuse gallbladder wall thickening, intramural hypo-attenuated nodules, and luminal surface enhancement are associated with xanthogranulomatous cholecystitis [6]. Shuto et al. concluded that hypo-attenuated nodules on CT corresponds to either xanthogranuloma consisting of foamy histiocytes or abscess/necrosis [7]. MRI can further differentiate xanthogranuloma from abscess/necrosis. On MRI, areas of isoto-high signal intensity on T2 weighted images that have slight enhancement on early and strong enhancement on late phase are representative of xanthogranulomas. Areas of high intensity on T2 weighted images without enhancement on early or delayed phase are representative of abscess/necrosis.
As seen in this case series, xanthogranulomatous cholangitis can mimic malignancies, such as cholangiocarcinoma. Other benign diseases that can mimic cholangiocarcinoma includes primary sclerosing cholangitis, recurrent pyogenic cholangitis, inflammatory pseudotumor, and Mirizzi syndrome [8]. It can be difficult to rule out cholangiocarcinoma preoperatively, and in many cases, surgery is needed to definitely rule out cancer. Although rare, xanthogranulomatous cholangitis should be included in the differential diagnosis of biliary abnormalities.
4. Conclusion
We present a patient with initial workup concerning for intrahepatic cholangiocarcinoma. Following liver resection, the final pathology showed xanthogranulomatous cholangitis with no malignancy. Review of literature suggests that patients often present with jaundice, and that many of the patients have preoperative workups concerning for malignancy. Most patients ultimately undergo surgical resection, with pathology confirming the diagnosis of xanthogranulomatous cholangitis. Even though xanthogranulomatous cholangitis is rare, it should be included in the differential diagnosis of biliary abnormalities.
Ethical approval
Not applicable.
Registration of research studies
Not applicable.
Guarantor
Jenny Zhang, Rachel Beard.
Consent
Written and verbal consent was obtained from the patient for publication.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Provenance and peer review
Not commissioned, externally peer-review.
Credit authorship contribution statement
Jenny Q. Zhang: study concept, data collection, data analysis, writing paper.
Lance Truong: data collection, data analysis, writing paper.
Jason Pan: data collection, data analysis, writing paper.
Evgeny Yakirevich: data collection, data analysis, writing paper.
Sarah M. Hyder: data collection, data analysis, writing paper.
Rachel E. Beard: data collection, data analysis, writing paper.
Declaration of competing interest
None.
References
- 1.Bae S.K., Abiru S., Kamohara Y., et al. Hepatic inflammatory pseudotumor associated with xanthogranulomatous cholangitis mimicking cholangiocarcinoma. Intern. Med. 2015;54(7):771–775. doi: 10.2169/internalmedicine.54.2623. [DOI] [PubMed] [Google Scholar]
- 2.Agha R.A., Fowler A.J., Saeta A., et al. The SCARE statement: consensus-based surgical case report guidelines. Int. J. Surg. Oct 2016;34:180–186. doi: 10.1016/j.ijsu.2016.08.014. [DOI] [PubMed] [Google Scholar]
- 3.Agha R.A., Sohrabi C., Mathew G., et al. The PROCESS 2020 guideline: updating consensus Preferred Reporting Of CasESeries in Surgery (PROCESS) guidelines. Int. J. Surg. Dec 2020;84:231–235. doi: 10.1016/j.ijsu.2020.11.005. [DOI] [PubMed] [Google Scholar]
- 4.Senthil Kumar M.P., Marudanayagam R. Klatskin-like lesions. HPB Surg. 2012;2012 doi: 10.1155/2012/107519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Singh V.P., Rajesh S., Bihari C., Desai S.N., Pargewar S.S., Arora A. Xanthogranulomatous cholecystitis: what every radiologist should know. World J. Radiol. 2016;8(2):183–191. doi: 10.4329/wjr.v8.i2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhao F., Lu P.-X., Yan S.-X., et al. CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases. Eur. J. Radiol. Sep 2013;82:1391–1397. doi: 10.1016/j.ejrad.2013.04.026. [DOI] [PubMed] [Google Scholar]
- 7.Shuto R., Kiyosue H., Komatsu E., et al. CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings. Eur. Radiol. Mar 2004;14:440–446. doi: 10.1007/s00330-003-1931-7. [DOI] [PubMed] [Google Scholar]
- 8.Menias C.O., Surabhi V., Prasad S.R., Wang H.L., Narra V.R., Chintapalli K.N. Mimics of cholangiocarcinoma- spectrum of disease. RadioGraphics. 2008;28(4):1115–1129. doi: 10.1148/rg.284075148. [DOI] [PubMed] [Google Scholar]
- 9.Goldar- Najafi A., Khettry U. Xanthogranulomatous choledochitis- a previously undescribed mass lesion of the hepatobiliary and ampullary region. Semin. Liver Dis. 2003;23(1):101–106. doi: 10.1055/s-2003-37589. [DOI] [PubMed] [Google Scholar]
- 10.Pantanowitz L., Goldar-Najafi A., Nasser I. Xanthogranulomatous choledochitis mimicking cholangiocarcinoma. Pathol. Int. 2004;54:213–215. doi: 10.1111/j.1440-1827.2004.01610.x. [DOI] [PubMed] [Google Scholar]
- 11.Kawate S., Ohwada S., Ikota H., Hamada K., Kashiwabara K., Yasuo M. Xanthogranulomatous cholangitis causing obstructive jaundice- a case report. World J. Gastroenterol. 2006;12(27):4428–4430. doi: 10.3748/wjg.v12.i27.4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Krishna R.P., Kumar A., Singh R.K., Sikora S., Saxena R., Kapoor V.K. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management. J. Gastrointest. Surg. May 2008;12(5):836–841. doi: 10.1007/s11605-008-0478-y. [DOI] [PubMed] [Google Scholar]
- 13.Alsheik E., Matin A., Sass D. Xanthogranulomatous cholecystitis and cholangitis: a single case study. Am. J. Gastroenterol. 2010;105(1):S213–S214. [Google Scholar]
- 14.Jun M., Hua F., Ping W., Jian-tao K., Qing H. Lower bile duct stenosis caused by xanthogranulomatous cholangitis complicated with jaundice. Chin. Med. J. 2013;126(23):4600. doi: 10.3760/cma.j.issn.0366-6999.20132234. [DOI] [PubMed] [Google Scholar]
- 15.Garg P.K., Pandey D., Mridha A.R., Shakya R., Sharma J. Xanthogranulomatous inflammation of gallbladder and bile duct causing obstructive jaundice masquerades gallbladder cancer: a formidable diagnostic challenge continues. J. Gastrointest. Cancer. Dec 2014;45(Suppl 1):178–181. doi: 10.1007/s12029-014-9620-0. [DOI] [PubMed] [Google Scholar]
- 16.Zbaida R.A., Schubert P.T., Banieghbal B. Pediatric Xanthogranulomatus cholangitis. J Pediatr Surg Case Rep. 2018;36:58–61. doi: 10.1016/j.epsc.2018.06.018. [DOI] [Google Scholar]
- 17.Ikezawa K., Wada H., Nakatsuka S., Takada R., Fukutake N., Ohkawa K. Gastrointestinal: Xanthogranulomatous cholangitis diagnosed by endoscopic ultrasound-guided fine-needle aspiration. J. Gastroenterol. Hepatol. Sep 2020;35(9):1464. doi: 10.1111/jgh.14953. [DOI] [PubMed] [Google Scholar]


